Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Evaluation on the safety of a group A + C meningococcal polysaccharide vaccine].
Dong BQ, Ye Q, Cui XL, Yang J, Gong J, Yang M, Liao HZ, Wei SL, Zhang J, Wu XH, Si GA, Yang HH, Tsuzuki A, Park J, Ali M, Ochiai LR, Clemens JD. Dong BQ, et al. Among authors: park j. Zhonghua Liu Xing Bing Xue Za Zhi. 2007 May;28(5):417-21. Zhonghua Liu Xing Bing Xue Za Zhi. 2007. PMID: 17877164 Clinical Trial. Chinese.
Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, Deen J, Acosta CJ, Chen Y, Wang H, Galindo CM, Ochiai L, Park T, von Seidlein L, Xu ZY, Clemens JD. Zhou WZ, et al. Among authors: park jk, park t. Pediatr Infect Dis J. 2007 Nov;26(11):1001-5. doi: 10.1097/INF.0b013e31812565bc. Pediatr Infect Dis J. 2007. PMID: 17984806 Clinical Trial.
A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial.
Yang J, Acosta CJ, Si GA, Zeng J, Li CY, Liang DB, Ochiai RL, Page AL, Danovaro-Holliday MC, Zhang J, Zhou BD, Liao HZ, Wang ML, Tan DM, Tang ZZ, Gong J, Park JK, Ali M, Ivanoff B, Liang GC, Yang HH, Pang T, Xu ZY, Donner A, Galindo CM, Dong BQ, Clemens JD. Yang J, et al. Among authors: park jk. BMC Public Health. 2005 May 18;5:49. doi: 10.1186/1471-2458-5-49. BMC Public Health. 2005. PMID: 15904514 Free PMC article. Clinical Trial.
The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy.
Thiem VD, Danovaro-Holliday MC, Canh DG, Son ND, Hoa NT, Thuy DT, Ochiai RL, Lan NT, Hop TQ, Ali M, Park JK, Abu-Elyazeed R, Holliday K, Ivanoff B, Anh DD, Pang T, Donner A, Galindo CM, Trach DD, Clemens JD, Acosta CJ. Thiem VD, et al. Among authors: park jk. Southeast Asian J Trop Med Public Health. 2006 May;37(3):515-22. Southeast Asian J Trop Med Public Health. 2006. PMID: 17120972 Clinical Trial.
A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD. Sur D, et al. Among authors: park jk. N Engl J Med. 2009 Jul 23;361(4):335-44. doi: 10.1056/NEJMoa0807521. N Engl J Med. 2009. PMID: 19625715 Free article. Clinical Trial.
Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.
Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, Lopez AL, Clemens JD, Deen JL, Shin S, Schaetti C, Hutubessy R, Aguado MT, Kieny MP, Sack D, Obaro S, Shaame AJ, Ali SM, Saleh AA, von Seidlein L, Jiddawi MS. Hashim R, et al. Among authors: park jk. PLoS Negl Trop Dis. 2012;6(7):e1743. doi: 10.1371/journal.pntd.0001743. Epub 2012 Jul 24. PLoS Negl Trop Dis. 2012. PMID: 22848772 Free PMC article.
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
Acosta CJ, Galindo CM, Ali M, Elyazeed RA, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD, Jin Y, Park JK, Lee H, Puri MK, Ivanoff B, Agtini MD, Soeharno R, Simanjuntak CH, Punjabi NH, Canh DG, Sur D, Nizami Q, Manna B, Bai-qing D, Anh DD, Honghui Y, Bhattacharya SK, Bhutta Z, Trach DD, Xu ZY, Pang T, Donner A, Clemens JD. Acosta CJ, et al. Among authors: park jk. Trop Med Int Health. 2005 Dec;10(12):1219-28. doi: 10.1111/j.1365-3156.2005.01517.x. Trop Med Int Health. 2005. PMID: 16359401 Free article. Clinical Trial.
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. Sur D, et al. Among authors: park jk. Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Lancet. 2009. PMID: 19819004 Clinical Trial.
71,044 results
You have reached the last available page of results. Please see the User Guide for more information.